Stability indicating analytical method development and validation of eltrombopag olamine in tablet dosage form by RP-UPLC
Open Access
- 30 October 2020
- journal article
- research article
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 7 (3) , 845-850
Abstract
A simple, precise and accurate stability indicating isocratic Reverse Phase Ultra-Performance Liquid Chromatographic (RP-UPLC) method was developed for quantitative determination of Eltrombopag olamine in the presence of degradant products. The method was developed using Acquity UPLC BEH C18 (50 × 2.1 mm, 1.7 μm) column with mobile phase containing a mixture of water (pH 3 with 30 % formic acid) and acetonitrile in ratio 30:70. The eluted compound was monitored at 244 nm and run time was within 2 min. Eltrombopag olamine was subjected to the stress condition of oxidative, acid, base, thermal and photolytic degradation. The drug was found to degrade significantly in acid, base and oxidative stress condition and stable in thermal and photolytic degradation condition. The degradation products were well resolved from main peak, providing stability indicating power of the method. The developed method was validated as per ICH Q2(R1) guideline with Linearity range was between 25-75 μg/ml, % Recovery range was found as 99.8-101.9 and Precision was found as RSD less than 2.Keywords
This publication has 8 references indexed in Scilit:
- Stability Indicating UHPLC Method Development and Validation for Estimation of Eltrombopag and its Related Impurities in Tablet Dosage formOriental Journal of Chemistry, 2018
- Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safetyTherapeutic Advances in Drug Safety, 2018
- Development and Validation of a Stability-indicating RP-HPLC Method for the Estimation of Eltrombopag in Bulk and Tablet FormulationAsian Journal of Chemical Sciences, 2018
- Spectrophotometric Method for Determination of Eltrombopag in Bulk and Pharmaceutical FormulationInternational Journal of Research in Pharmacy and Biosciences, 2017
- RP-UPLC-MS Assay Method for Eltrombopag: Application in Pharmaceuticals, Human Plasma and Urine SamplesAsian Journal of Chemistry, 2015
- Liquid chromatography–tandem mass spectrometric assay for eltrombopag in 50μL of human plasma: A pharmacokinetic studyJournal of Pharmaceutical and Biomedical Analysis, 2014
- Development of forced degradation and stability indicating studies of drugs—A reviewJournal of Pharmaceutical Analysis, 2014
- Eltrombopag: An Oral Thrombopoietin Receptor Agonist for the Treatment of Idiopathic Thrombocytopenic PurpuraClinical Therapeutics, 2011